After attachment to receptors, reovirus virions are internalized by endocytosis and exposed to aciddependent proteases that catalyze viral disassembly. Previous studies using the cysteine protease inhibitor E64 and a mutant cell line that does not support reovirus disassembly suggest a requirement for specific endocytic proteases in reovirus entry. This study identifies the endocytic proteases that mediate reovirus disassembly in murine fibroblast cells. Infection of both L929 cells treated with the cathepsin L inhibitor Z-Phe-Tyr(tBu)-diazomethyl ketone and cathepsin L-deficient mouse embryo fibroblasts resulted in inefficient proteolytic disassembly of viral outer-capsid proteins and decreased viral yields. In contrast, both L929 cells treated with the cathepsin B inhibitor CA-074Me and cathepsin B-deficient mouse embryo fibroblasts support reovirus disassembly and growth. However, removal of both cathepsin B and cathepsin L activity completely abrogates disassembly and growth of reovirus. Concordantly, cathepsin L mediates reovirus disassembly more efficiently than cathepsin B in vitro. These results demonstrate that either cathepsin L or cathepsin B is required for reovirus entry into murine fibroblasts and indicate that cathepsin L is the primary mediator of reovirus disassembly. Moreover, these findings suggest that specific endocytic proteases can determine host cell susceptibility to infection by intracellular pathogens.
Endocytic proteases play important roles in propagating signals from the cell surface, processing molecules for distribution to appropriate intracellular organelles, and generation of antigen-specific immune responses. Endocytic proteases also act on internalized microorganisms, in some cases mediating their destruction, but in others, removing components that allow subsequent steps in the infectious cycle. Although endocytic proteases engage in nonspecific bulk hydrolysis within lysosomes, there are several examples of specific biologic functions mediated by individual endocytic proteases (1) . For example, in epithelial cells of the thymic cortex, cathepsin L plays a key role in cleaving the CLIP peptide, allowing for antigen presentation in the context of MHC class II molecules. As a result, cathepsin L-deficient mice are immunodeficient due to a defect in positive selection of T cells (2) . In addition, cathepsin L is required for regulation of hair growth, and cathepsin L-deficient mice are "furless" (3) . Cathepsin B can modulate pathological trypsinogen activation (4) and apoptosis induced by tumor necrosis factor-␣ (5). To better understand the role and specificity of endocytic proteases in virus-host interactions, we studied the proteolytic disassembly of reovirus.
Mammalian reoviruses are nonenveloped viruses that contain a segmented, double-stranded RNA genome. In comparison to enveloped viruses, less is known about cell entry mechanisms of nonenveloped viruses, a group that includes several important human pathogens. Mammalian reoviruses are a useful experimental system to study cell entry of nonenveloped viruses, as discrete steps in the viral entry pathway have been defined. Reovirus particles consist of two concentric protein shells, the outer capsid and core. After engagement of cellsurface receptors including junctional adhesion molecule-1 (6) and sialic acid (7) (8) (9) (10) (11) (12) (13) , reovirus virions enter cells by receptormediated endocytosis (14 -16) . Within the endocytic compartment, virions are exposed to acid-dependent proteases, which catalyze formation of infectious subvirion particles (ISVPs). 1 Endocytic proteases degrade outer-capsid protein 3 and cleave outer-capsid protein 1/1C to form particle-associated fragments 1␦/␦ and (for review, see Ref. 17) . ISVPs are capable of penetrating membranes, thereby delivering transcriptionally active core particles into the cytoplasm (18 -22) .
Previous studies suggest that reovirus disassembly is dependent on specific endocytic proteases. Treatment of cells with the cysteine protease inhibitor E64 (23) blocks steps in reovirus disassembly required for generation of ISVPs (24 -26) . Treatment of reovirus virions with purified cathepsin L leads to formation of particles that have the biochemical and growth properties of ISVPs generated in vitro by treatment of virions with intestinal proteases (27) . In contrast, treatment of cells with the aspartic protease inhibitor pepstatin A (28) does not alter reovirus entry and growth (29) , and treatment of virions with cathepsin D does not result in generation of ISVPs (26, 29) . These findings suggest that endocytic cysteine proteases but not aspartic proteases are required for reovirus disassembly.
Persistent reovirus infection of murine L929 (L) cells selects mutant (LX) cells that do not support viral disassembly within the endocytic pathway. Studies of mutant LX cells provide further evidence that reovirus entry is dependent on specific proteases. Infection of LX cells with virions does not result in viral growth, whereas infection with ISVPs does (30) . These findings indicate that LX cells have a defect in viral entry steps leading to formation of ISVPs. Parental L cells and mutant LX cells do not differ in the capacity to internalize reovirus virions, acidify intracellular compartments, or deliver virions to acidified organelles. However, in contrast to parental L cells, the activity of two cysteine endocytic proteases, cathepsin B and cathepsin L (27) , 2 is absent in mutant LX cells. The activity of a third cysteine protease, cathepsin H, is equivalent in parental L cells and mutant LX cells. These findings provide further support for the idea that cysteine proteases mediate disassembly of reovirus virions.
To identify the specific endocytic proteases that uncoat reovirus virions in fibroblast cells, L cells were treated with specific inhibitors of cathepsin B and cathepsin L and tested for the capacity to support reovirus disassembly and growth. Similar assays were performed using mouse embryo fibroblasts (MEFs) derived from cathepsin B-deficient mice and cathepsin L-deficient mice. Finally, the in vitro disassembly of virions to ISVPs by purified cathepsin B and cathepsin L was compared. These studies indicate that cathepsin B and cathepsin L mediate reovirus disassembly in cellular endosomes. Moreover, these studies delineate a new, physiologically relevant substrate for cathepsin B and cathepsin L.
EXPERIMENTAL PROCEDURES
Cells and Viruses-Murine L929 (L) cells were grown in either suspension or monolayer cultures in Joklik's modified Eagle's minimal essential medium (Irvine Scientific, Santa Ana, CA) supplemented with 5% fetal bovine serum (Intergen, Purchase, NY), 2 mM L-glutamine, 100 units of penicillin/ml, 100 g of streptomycin/ml, and 0.25 g of amphotericin/ml (Irvine). MEFs, derived from cathepsin L Ϫ/Ϫ and cathepsin L ϩ/ϩ mice (3) or cathepsin B Ϫ/Ϫ and cathepsin B ϩ/ϩ mice (31, 32) , were grown in monolayer cultures in Dulbecco's minimal essential medium (Invitrogen) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 units of penicillin/ml, and 100 g of streptomycin/ml. Reovirus strains type 1 Lang (T1L) and type 3 Dearing (T3D) are laboratory stocks. Purified virion preparations were made using second-passage L-cell lysate stocks of twice-plaque-purified reovirus as previously described (33) . Purified virions containing 35 S-labeled proteins were obtained by adding Easy Tag Express- 35 S protein labeling mix (PerkinElmer Life Sciences) to cell suspensions (ϳ12.5 Ci/ml) at the initiation of infection. ISVPs were prepared by treating purified T1L virions with N␣-p-tosyl-L-lysine chloromethyl ketonetreated bovine ␣-chymotrypsin (Sigma) as previously described (24) .
Specificity of Protease Inhibitors-The cathepsin B inhibitor CA074Me (B I ) (Peptides International, Louisville, KY), the cathepsin L inhibitor Z-Phe-Tyr(t-Bu)-diazomethyl ketone (L I ) (Calbiochem-Novabiochem), the cathepsin B substrate Z-Arg-Arg-MCA (Peptides International), and the cathepsin L substrate (Z-Phe-Arg) 2 -R110 (Molecular Probes, Eugene, OR) were dissolved in Me 2 SO to generate a 10 mM stock that was separated into aliquots, and frozen. CA-074Me specifically inhibits intracellular cathepsin B (34 -36) , whereas Z-Phe-Tyr(tBu)-diazomethyl ketone specifically inhibits cathepsin L (37) .
Cathepsin B activity was measured by preincubating L cells (2 ϫ 10 6 ) in 1.5-ml microcentrifuge tubes in 1 ml of medium supplemented to contain 0 -10 M B I or 0 -10 M L I at 37°C for 1 h. Cells were washed twice with phosphate-buffered saline (PBS) and resuspended in 100 l of lysis buffer (100 mM sodium acetate (pH 5), 1 mM EDTA, 0.5% Triton X-100). Insoluble material was sedimented in a microcentrifuge at 4°C. In a black 96-well plate (Costar), 20 l of cell lysate was mixed with 80 l of reaction buffer (100 mM sodium acetate (pH 5), 1 mM EDTA, 4 mM dithiothreitol (DTT), and 100 l of substrate solution (100 M Z-ArgArg-MCA diluted in 0.1% Brij 35 (Sigma)) (38) . After incubation at room temperature for 30 min, fluorescence was measured using a FLUOstar 403 fluorometer (BMG LabTechnologies, Durham, NC) with an excitation of 390 nm and emission at 460 nm. Cathepsin L activity was measured by preincubating L cells (5 ϫ 10 6 ) in 1.5-ml microcentrifuge tubes in 1 ml of medium supplemented to contain 0 -10 M B I or L I at 37°C for 1 h. Cells were washed once with PBS and resuspended in PBS supplemented with 0 -10 M protease inhibitors and 50 M (Z-PheArg) 2 -R110. After incubation at 37°C for 90 min, 200-l aliquots were added to a black 96-well plate. Fluorescence was measured using a FLUOstar 403 fluorometer with an excitation of 485 nm and an emission at 510 nm.
Growth of Reovirus in Cells Treated with Protease Inhibitors-Monolayers of L cells (4 ϫ 10 5 ) in 24-well plates (Costar) were preincubated for 1 h in medium supplemented to contain 0 -10 M B I or 0 -10 M L I . The medium was removed, and cells were adsorbed with reovirus at a multiplicity of infection (m.o.i.) of 2 plaque-forming units (pfu)/cell in gel saline (39) . After a 1-h incubation at 4°C, cells were washed once with PBS, and 1 ml of fresh medium supplemented with 0 -10 M protease inhibitors was added. Alternatively, MEFs (2 ϫ 10 5 ) in 24-well plates were preincubated with medium supplemented with 0 -1 M B I or 0 -1 M L I at 37°C for 1 h. The medium was removed, and cells were adsorbed with reovirus at an m.o.i. of 2 pfu/cell. After incubation at room temperature for 30 min, cells were washed once with PBS, and 1 ml of fresh medium supplemented with 0 -1 M protease inhibitors was added. After incubation at 37°C for 24 h, cells were frozen and thawed twice, and viral titers in cell lysates were determined by plaque assay (39) . Independent experiments were performed using single wells of cells, which were titrated in triplicate.
Proteolysis of Reovirus Outer-capsid Proteins during Cell EntryMonolayers of L cells (1 ϫ 10 7 ) in 100-mm dishes (Costar) were preincubated for 1 h in medium supplemented to contain 0 -10 M B I or 0 -10 M L I . The medium was removed, and cells were adsorbed with purified 35 S-labeled reovirus virions at an m.o.i. of 10,000 particles/cell. After incubation at 4°C for 1 h, the inoculum was removed, cells were washed twice with PBS, and 5 ml of fresh medium supplemented with 0 -10 M protease inhibitors was added. Alternatively, MEFs (3 ϫ 10 6 ) in 100-mm dishes were preincubated with 0 -1 M B I or 0 -1 M L I and infected as described for L cells. After incubation at 37°C for 0 -3 h, cells were suspended by scraping and collected by centrifugation at 528 ϫ g for 5 min. Cells were resuspended in 0.5 ml of lysis buffer (150 mM NaCl, 10 mM Tris (pH 7.4), 0.5% Nonidet P-40, 1 mM EDTA, 1 mM benzamidine (Sigma), 100 mM leupeptin (Sigma), 2.5 mM phenylmethylsulfonyl fluoride) and placed on ice for 5 min, and 4.0 ml of homogenization buffer (250 mM NaCl, 10 mM Tris (pH 7.4), 0.067% 2-mercaptoethanol) was added. Samples were sonicated for 15 s, 2.5 ml of Freon (EM Science, Gibbstown, NJ) was added, and samples were again sonicated for 20 s. Samples were centrifuged at 9700 ϫ g for 10 min, and the aqueous fraction was placed into 13 ϫ 51-mm centrifuge tubes (Beckman Instruments). Virus particles were pelleted by centrifugation in an SW50.1 rotor (Beckman) at 210,000 ϫ g for 1 h. Pelleted particles were resuspended in 30 -50 l of 1ϫ sample buffer (125 mM Tris, 2% 2-mercaptoethanol, 1% SDS, 0.01% bromphenol blue) and frozen at Ϫ20°C.
Transfection of Cathepsin L-deficient MEFs-Monolayers of MEFs (2 ϫ 10 5 ) in 24-well plates were transfected using LipofectAMINE Plus (Invitrogen) with 0.4 g of the eukaryotic expression vector pSG5 (Stratagene, La Jolla, CA) or pSG5 into which a cDNA encoding murine procathepsin L had been cloned (40) . After a 24-h incubation, transfected cells were infected with virus at an m.o.i. of 2 pfu/cell.
Fluorescent Focus Assay of Viral Infectivity-Virus inocula were adsorbed to confluent MEF monolayers (1 ϫ 10 5 cells) in 24-well plates as for growth experiments. After incubation at 37°C for 18 h to permit completion of a single round of viral replication, cell monolayers were fixed with 1 ml of methanol at -20°C for a minimum of 30 min. Fixed monolayers were washed twice with PBS, blocked with 5% immunoglobin-free bovine serum albumin (Sigma) in PBS, and incubated at 37°C for 30 min with protein A-affinity-purified polyclonal rabbit anti-reovirus serum at a 1:500 dilution in PBS, 0.5% Triton X-100. Monolayers were washed twice with PBS, 0.5% Triton X-100 and incubated with a 1:1000 dilution of anti-rabbit immunoglobulin serum conjugated with Alexa-488 (Molecular Probes). Monolayers were washed twice with PBS, 0.5% Triton X-100, and infected cells were visualized by indirect immunofluorescence. Infected cells were identified by the presence of intense cytoplasmic fluorescence that was excluded from the nucleus (41) . Background staining in uninfected control monolayers was not detected.
SDS-PAGE of Reovirus Structural
Proteins-Discontinuous SDS-PAGE was performed as previously described (42) . Viral particles were solubilized by incubation in sample buffer (125 mM Tris, 2% 2-mercap-2 D. Ebert and T. Dermody, unpublished results. toethanol, 1% SDS, 0.01% bromphenol blue) at 100°C for 5 min. Samples were loaded into wells of 10% polyacrylamide gels and electrophoresed at a 200-V constant voltage for 1 h. After electrophoresis, gels were fixed, dried onto filter paper (Bio-Rad) under vacuum, and exposed to BioMax film (Eastman Kodak Co.).
Densitometric Analysis of Reovirus Outer-capsid Proteins-Dried gels containing 35 S-labeled reovirus virions were exposed to an imaging plate, and band intensities were quantitated by determining photostimulus luminescence units using a FLA-2000 fluorescent image analyzer (Fuji Medical Systems, Inc., Stamford, CT). For each lane, mean densities were determined for bands corresponding to the reovirus 2 and 3 proteins. Densities of bands corresponding to 3 were divided by those corresponding to 2 as a control for loading. Core protein 2 is not degraded during protease treatment of virions to generate ISVPs (11, 14, 16, (43) (44) (45) . To statistically compare 3/2 ratios between two different conditions, one-tailed, two-sample t tests assuming unequal variance were calculated using Excel 97 (Microsoft, Redmond, WA). 35 S-labeled reovirus virions at a concentration of 1 ϫ 10 12 particles/ml in reaction buffer (50 mM sodium acetate (pH 5.0), 3 mM DTT) were treated with 0 -4 M purified recombinant human cathepsin L (46) or 0 -4 M purified bovine spleen cathepsin B (Calbiochem-Novabiochem) at 37°C for 8 h. Alternatively, purified reovirus virions at a concentration of 1 ϫ 10 12 particles/ml in reaction buffer (50 mM sodium acetate (pH 5.0), 100 mM NaCl, 3 mM DTT) were treated with 1 M cathepsin L at 37°C for various intervals. A 25-l aliquot of each reaction was mixed with 5 l of 6ϫ sample buffer (350 mM Tris (pH 6.8), 9.3% DTT, 10% SDS, 0.012% bromphenol blue) and incubated at 100°C for 5 min. Samples were loaded into wells of 10% polyacrylamide gels and electrophoresed at a 200-V constant voltage. After electrophoresis, gels were fixed, dried onto filter paper under vacuum, and exposed to BioMax film (Kodak).
Treatment of Reovirus Virions with Purified Cathepsins-Purified
Identification of Cathepsin L Cleavage Sites in T1L-Purified T1L virions at a concentration of 8 ϫ 10
12 particles/ml in reaction buffer (50 mM sodium acetate (pH 5.0), 100 mM NaCl, 3 mM DTT) were treated with 25 g of cathepsin L/ml at 37°C for 1 h. Samples were loaded into wells of 14% polyacrylamide gels and electrophoresed at 200 V. After electrophoresis, viral proteins were transferred to polyvinylidene difluoride membranes (Bio-Rad) at 400 mA for 20 min. Membranes were stained with Coomassie Blue. The 13-kDa fragment was excised from the membrane, and the N terminus was sequenced using Edman degradation by the Vanderbilt Protein Chemistry Laboratory. Cathepsin L cleavage sites were modeled onto the 3 structure (47) using Swiss PDB viewer 3.7 (Glaxo Wellcome) and POV-Ray (Persistence of Vision Development Team).
RESULTS

Specificity of Protease
Inhibitors-As a prelude to experiments to determine the effects of both an inhibitor of cathepsin L, Z-Phe-Tyr(t-Bu)-diazomethyl ketone (L I ), and an inhibitor of cathepsin B, CA-074Me (B I ), on reovirus disassembly and growth, we first tested the specificity of these protease inhibitors using fluorogenic protease substrates. De-esterification of the membrane-permeable proinhibitor CA-074Me inside cells generates the specific cathepsin B inhibitor CA-074 (36) . Cathepsin B activity was measured by incubating cell lysates with the cathepsin B-specific substrate Z-Arg-Arg-MCA (38) . Cathepsin L activity was measured by incubating intact cells with (Z-Phe-Arg) 2 -R110, which is cleaved 820 times more efficiently by cathepsin L than cathepsin B (48, 49) . In L cells treated with 1 M B I , cathepsin B activity was reduced to 1% of that in untreated cells (Fig. 1A) , whereas cathepsin L activity was 87% that in untreated cells (Fig. 1B) . In contrast, cathepsin B activity in L cells treated with 3.3 M L I was 90% that in untreated cells, whereas cathepsin L activity was only 2.6% that in untreated cells. At 10 M L I , cathepsin L activity was further 
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reduced to 2% of untreated cells, whereas cathepsin B activity was reduced to 53% of untreated cells. Because cathepsin B is capable of cleaving the substrate (Z-Phe-Arg) 2 To provide evidence that the observed inhibition of viral growth by treatment with B I and L I is due to inhibition of proteolytic disassembly of virions, cells were infected with ISVPs of strain T1L generated in vitro by chymotrypsin treatment of purified virions. ISVPs can grow in cells treated with inhibitors of virion-to-ISVP disassembly but not in cells treated with inhibitors of subsequent steps in the viral replication cycle (17) . Viral yields after infection with ISVPs were equivalent in the presence and absence of B I and L I (Fig. 1C) . These results suggest that the blockade of viral growth in L cells treated with inhibitors of cathepsin B and cathepsin L is due to blockade of virion-to-ISVP disassembly.
To demonstrate directly that differences in growth of virions in L cells treated with cathepsin B and cathepsin L inhibitors are linked to differences in viral disassembly, 35 S-labeled virions of T1L were adsorbed to L cells that had been pretreated with 0 -10 M B I and L I . After 0 or 3 h of incubation in media supplemented with or without B I and L I , viral structural proteins were resolved by SDS-PAGE and visualized by autoradiography ( Fig. 2A) . Degradation of outer-capsid protein 3 and cleavage of outer-capsid protein 1C to ␦, changes indicative of ISVP formation, were observed after 3 h of incubation in untreated cells. Degradation of 3 and generation of ␦ also occurred in cells treated with 1 M B I . In contrast, degradation of 3 and cleavage of 1C occurred to a significantly lesser extent in cells treated with 3.3 M L I than in untreated cells. Because viral core protein 2 is not degraded during viral entry, band intensity of the 2 protein was used to normalize for potential discrepancies in sample preparation and loading (Fig. 2B) . Using a one-tailed, two-sample t test assuming unequal variance, the difference in the 3/2 ratio after infection of cells treated with 3. (Fig. 3A) . These results suggest that the absence of cathepsin L renders MEFs significantly less permissive for reovirus infection and that this block to reovirus infection can be removed by complementing cathepsin L.
Infection of wt MEFs with either T1L or T3D results in robust viral growth, with viral yields of 47 and 435, respectively, after a single cycle of viral replication. In contrast, yields of T1L and T3D after infection of cathepsin L-deficient MEFs were 1.8-and 40-fold viral input, a reduction of 26-and 11-fold in comparison to yields after infection of wt MEFs. To test whether residual reovirus growth in cathepsin L-deficient MEFs is dependent on cathepsin B, MEFs were treated with B I before infection with reovirus. Treatment of wt MEFs with B I resulted in only a 2.9-fold decrease in yield of T3D in comparison to that after growth in untreated cells. However, treatment of cathepsin L-deficient MEFs with B I completely abolished viral growth. As a control, infection of MEFs treated with 0 -1 M B I with ISVPs resulted in essentially equivalent viral yields (Fig. 3B) . These results indicate that genetic ablation of cathepsin L in conjunction with pharmacologic inhibition of cathepsin B renders MEFs incapable of supporting reovirus replication and suggest that the block to viral growth occurs before generation of ISVPs.
To determine whether cathepsin L is required for MEFs to support reovirus disassembly, wt MEFs and cathepsin L-deficient MEFs were adsorbed with 35 S-labeled T1L virions, cells were lysed at various intervals, and viral proteins were resolved by SDS-PAGE. After infection of wt MEFs, 3 was rapidly degraded, and 1C was cleaved to form ␦. In contrast, infection of cathepsin L-deficient MEFs was associated with a significant delay of these cleavage events; 3 was degraded at a slower rate, whereas traces of ␦ generation were evident only at the latest time point (Fig. 4A ). In concordance with these results, at each time point after viral adsorption of cathepsin L-deficient MEFs, the 3/2 ratio was significantly greater than that after adsorption of wt MEFs (p Ͻ 0.0009 for 3 h, p Ͻ 0.02 for 6 h, p Ͻ 0.009 for 9 h) (Fig. 4B) . These results indicate that efficient proteolytic processing of the reovirus outer capsid requires cathepsin L.
To test whether cathepsin B is responsible for the residual capacity of cathepsin L-deficient MEFs to support reovirus disassembly, MEFs were pretreated with B I and adsorbed with 35 S-labeled T1L virions. Degradation of 3 and cleavage of 1C to ␦ were only slightly diminished after infection of B I -treated wt MEFs in comparison to untreated MEFs (Fig. 5A) . As anticipated, the 3/2 ratio after infection of wt MEFs treated with B I was slightly higher than that after infection of untreated MEFs. However, after treatment of cathepsin L-deficient MEFs with B I , the modest degradation of 3 and cleavage of 1C to ␦ observed 9 h after infection of untreated cells was 6 ) were adsorbed with 1 ϫ 10 11 purified 35 S-labeled T1L virions. After incubation at room temperature for 30 min, the inoculum was removed, fresh medium with or without B I was added, and cells were incubated at 37°C for 0, 3, 6, or 9 h. Viral particles in cell lysates were subjected to SDS-PAGE. Viral proteins are labeled on the right. B, quantitation of 3 band intensity. The densities of bands corresponding to the 2 and 3 proteins were determined, and the results are expressed as the mean 3/2 ratios for three independent experiments. Error bars indicate S.D. not observed. At this late time point, ␦ formation was not evident, and the 3 band intensity and the 3/2 ratio were equivalent to those at the 0-h time point in B I -treated cathepsin L-deficient MEFs (Fig. 5, A and B) . Thus, inefficient proteolytic disassembly of reovirus virions in cathepsin L-deficient MEFs appears entirely dependent on cathepsin B.
Viral Growth and Disassembly in Cathepsin B-deficient MEFs-To more precisely define the role of cathepsin B in reovirus entry, cathepsin B-deficient MEFs were infected with reovirus virions, and viral yields were determined after 24 h of viral growth. Infection with either T1L or T3D resulted in approximately equivalent yields in wt MEFs and cathepsin B-deficient MEFs (Fig. 6) . In concordance with studies using L cells treated with B I , these results indicate that the absence of cathepsin B does not alter the capacity of MEFs to support reovirus growth.
Because previous experiments suggested a requirement for either cathepsin B or cathepsin L in reovirus entry, we tested the effect of L I on reovirus growth in cathepsin B-deficient MEFs. Treatment of wt MEFs with L I resulted in 4 -5-fold reductions in yields of T1L and T3D in comparison to those in untreated wt MEFs. In contrast, treatment of cathepsin Bdeficient MEFs with L I resulted in 55-600-fold lower viral yields in comparison to those after growth in untreated cathepsin B-deficient MEFs. In fact, viral yields in L I -treated cathepsin B-deficient MEFs were only 0.5-2-fold greater than viral input (Fig. 6) . Thus, cathepsin B-deficient MEFs are much more sensitive than wt MEFs to the inhibitory effects of L I on viral growth. Moreover, growth of reovirus in cathepsin Bdeficient MEFs can be completely abrogated by treatment with an inhibitor of cathepsin L.
To determine whether cathepsin B-deficient MEFs can support disassembly of reovirus virions, 35 S-labeled T1L virions were adsorbed to cathepsin B-deficient MEFs, cells were lysed at different times, and viral proteins were resolved by SDS-PAGE (Fig. 7A) . In contrast to results obtained in experiments using cathepsin L-deficient MEFs, by 3 h after infection of cathepsin B-deficient MEFs, 3 was substantially degraded, and noticeable quantities of ␦ had accumulated. By 6 h after infection, more 3 was degraded, and greater amounts of ␦ were generated. However, in L I -treated cathepsin B-deficient MEFs, 3 and 1C remained intact, even at 6 h after adsorption. The 3/2 ratio after infection of cathepsin B-deficient MEFs treated with L I approximated that observed at the 0-h time point and was significantly greater than the 3/2 ratio after infection of wt MEFs at 6 h (p Ͻ 0.011) (Fig. 7B) . These results indicate that cathepsin B-deficient MEFs are not altered in the capacity to disassemble reovirus virions and that inhibition of cathepsin L prevents virion disassembly in cathepsin B-deficient MEFs.
Treatment of Reovirus Virions with Purified Endocytic Proteases-Because reovirus disassembly in murine fibroblasts is dependent on cathepsin B and cathepsin L, with cathepsin L appearing to play a more important role in this process, we compared the relative capacities of purified cathepsin B and cathepsin L to mediate reovirus disassembly in vitro. Equivalent numbers of 35 S-labeled virions of strain T1L were incubated with increasing concentrations of each enzyme. Outercapsid protein 3 was degraded with increasing concentrations of both cathepsin B (Fig. 8A ) and cathepsin L (Fig. 8B) . However, degradation of 3 occurred with substantially lower concentrations of cathepsin L. At 1 M enzyme, 3 was completely degraded by cathepsin L but minimally cleaved by cathepsin B. Even after incubation with 4 M cathepsin B, substantial amounts of 3 remained. Generation of the ␦ fragment was evident after incubation with 1 M cathepsin L but not 1 M During these experiments, we noted that cathepsin B cleavage of 3 produced a doublet band as full-length 3 was replaced by a fragment of slightly faster electrophoretic mobility (Fig. 8A) . To determine whether cathepsin L degrades 3 by a similar mechanism, virions of T1L were treated with 1 M cathepsin L over a time course, and viral structural proteins were resolved by SDS-PAGE (Fig. 8C) . Degradation of 3 by cathepsin L also resulted in a doublet band that preceded complete degradation of the protein. After incubation for 1 h, a faint band appeared that migrated slightly faster than fulllength 3. After incubation for 2-4 h, this lower band increased in intensity in direct proportion to the loss in intensity of the upper band. At times greater than 8 h, neither band was apparent (data not shown). After treatment of T1L virions with cathepsin L, the upper and lower bands were resolved by SDS-PAGE, excised from the gel, digested with trypsin, and analyzed by mass spectrometry. The tryptic fragments from the upper and lower bands had identical masses that matched predicted tryptic cleavage fragments of 3 (data not shown). These results suggest that an initial cleavage event by either cathepsin B or cathepsin L occurs near a terminus of the 3 protein.
Identification of Cathepsin L Cleavage Sites in T1L VirionsResults presented thus far indicate that cathepsin L is the major mediator of reovirus disassembly in endosomes of murine fibroblasts. To identify sites in 3 cleaved by cathepsin L, T1L virions were treated with purified cathepsin L, and the C-terminal 3 cleavage fragment was subjected to peptide sequencing. Cathepsin L treatment of T1L 3 results in ϳ13-and 29-kDa fragments after SDS-PAGE and Coomassie Blue staining, analogous to Staphylococcus aureus V8 protease treatment of T3D 3 (50, 51) . In studies using V8 protease, the smaller fragment corresponds to the C-terminal fragment. Based on this finding, the 13-kDa fragment generated by cathepsin L treatment of T1L virions was transferred to a polyvinylidene difluoride membrane and subjected to N-terminal peptide sequencing by Edman degradation. Two amino acid sequences were evident from this analysis (Fig. 9A) . The predominant sequence was HFGLS, which matches 3 amino acid residues 251-255. The minor sequence was TPARD, which corresponds to 3 amino acid residues 244 -248. Thus, sequence analysis of the 13-kDa 3 cleavage fragments generated by cathepsin L treatment of T1L virions indicates that cathepsin L cleaves 3 at two sites, between amino acids 250 and 251 and between amino acids 243 and 244. 
DISCUSSION
After receptor-mediated endocytosis, the reovirus outer capsid is subject to proteolysis by endocytic proteases, resulting in generation of ISVPs. These particles are obligate intermediates in reovirus disassembly that interact directly with vacuolar membranes leading to delivery of transcriptionally active viral cores into the cytoplasm (for review, see Ref. 17) . Previous studies suggest that specific endocytic proteases mediate disassembly of reovirus virions to ISVPs. Cysteine protease inhibitor E64 blocks reovirus disassembly (24 -26) , but aspartic protease inhibitor pepstatin A does not (29) . Mutant cells selected during persistent reovirus infection do not support reovirus disassembly despite internalizing and transporting virions to acidified, perinuclear compartments. These mutant cells have defects in the activity of cysteine proteases cathepsin B and cathepsin L but not cysteine protease cathepsin H (27) . 2 This study sought to identify the specific endocytic proteases that act on reovirus virions in endosomes of murine fibroblasts to generate functional ISVPs.
Studies using L cells and genetically deficient MEFs indicate that either cathepsin B or cathepsin L is required for reovirus virion-to-ISVP disassembly. Removal of cathepsin L activity alone, whether by active-site inhibitors or by genetic modification, significantly decreases the capacity of cells to support reovirus disassembly. In contrast, removal of cathepsin B activity alone does not alter the capacity of cells to support either disassembly or growth. However, removal of both cathepsin B and cathepsin L activity completely abrogates disassembly and growth of reovirus. In concordance with these data, cathepsin L mediates reovirus disassembly more efficiently than cathepsin B in vitro. Particles generated by cathepsin L treatment of T1L virions have biological hallmarks of ISVPs in that these particles bypass blocks to inhibitors of viral entry, such as E64 and ammonium chloride, and can infect mutant cells selected during persistent infection (27) . Thus, murine fibroblasts have a requirement for either cathepsin B or cathepsin L to support reovirus disassembly, although cathepsin L is the major mediator of this process.
Why reovirus has evolved so that only specific proteases can effect its disassembly within cellular endosomes is an interesting question. The answer may lie in the virion stability/disassembly fulcrum. There is selective pressure for a virus to be stable in the environment yet disassemble and activate its genetic program in the appropriate intracellular compartment. Requirement by a nonenveloped virus for specific endocytic proteases to mediate capsid removal would allow it to be stable in the environment where these proteases are either not present or present in inactive forms. Upon delivery to the appropriate endocytic organelle, the resident proteases contained therein, such as cathepsin B and cathepsin L, would catalyze viral disassembly and facilitate delivery of the virus into the cytoplasm.
Results presented here implicate the reovirus outer capsid as a physiologically relevant substrate for cathepsin B and cathepsin L. The outer capsid consists of 3 and 1 in 1:1 complexes, present at 600 copies/virion (52) (53) (54) . The 3 protein acts as a cap to protect 1, which is the viral protein that mediates membrane penetration (20 -22) . Thus, removal of 3 is essential to the disassembly process (16, 24) . Reovirus 3 is a bilobed protein with its N terminus in a virion-proximal smaller lobe bound to 1 and its C terminus in a virion-distal larger lobe (47, 55, 56) . Studies using S. aureus V8 protease suggest that 3 is sensitive to proteolytic cleavage near amino acid 220 (50), which is approximately positioned between the two lobes (47) .
We identified sites in T1L 3 cleaved by cathepsin L to provide additional evidence that 3 serves as a cathepsin L substrate and to gain insight into mechanisms of 3 cleavage in the endocytic pathway. Two cleavage sites were identified in the smaller of two stable 3 cleavage fragments produced after cathepsin L treatment. The more predominant species was produced after cleavage between amino acids 250 and 251, and a lower abundance product was produced after cleavage between amino acids 243 and 244. It is possible that cleavage at one site precedes cleavage at the other, or both sites may be used, albeit with different efficiencies. Cathepsin L prefers large hydrophobic residues at the P2 positions for efficient proteolysis (38) . The cathepsin L cleavage sites in T1L 3 determined here conform to this preference. At the cleavage site between amino acids 250 and 251, phenylalanine is present at the P2 position; at the cleavage site between amino acids 243 and 244, the P2 position is occupied by leucine.
The first observed cleavage event after treatment of reovirus virions with either cathepsin B or cathepsin L in vitro is a 3 band of slightly faster electrophoretic mobility than full-length 3. Mass spectrometric analysis of the faster migrating species generated by cathepsin L treatment of T1L virions confirmed that it is indeed formed from 3. These findings suggest that an initial cleavage event occurs at a 3 terminus. Previous studies from our laboratory show that PI viruses isolated from L-cell cultures persistently infected with reovirus strain T3D (24, 30) and D-EA mutant viruses isolated from serial passage of T3D in the presence of cysteine protease inhibitor E64 (26) are more sensitive to proteolytic cleavage by either chymotrypsin or cathepsin L than parental strain T3D. Furthermore, PI and D-EA viruses, unlike wt T3D, are capable of growth in cells treated with E64. For all tested PI and D-EA viruses, the 3-encoding S4 gene is the primary genetic determinant of resistance to E64-mediated inhibition of viral growth. Remarkably, all PI and D-EA viruses subjected to genetic analysis have a tyrosineto-histidine mutation at amino acid 354 in 3. For one of the PI viruses and two of the D-EA viruses, histidine 354 is the only mutation in 3. These findings suggest that the C terminus of 3 plays an important role in determining susceptibility of the protein to proteolytic attack. In addition, strain-specific differences in 3 susceptibility to proteolysis have been mapped to the C-terminal third of 3 using chimeric 3 molecules (57). Based on these studies and the analysis of the previously determined crystal structure of T3D 3 (47), it seems most likely that the initial cleavage event in 3 occurs near the C terminus in the vicinity of amino acid 354. Importantly, the C-terminal region of 3 and the cathepsin L cleavage sites identified in this study are adjacent to each other in the T3D 3 crystal structure (Fig. 9B) . Although the cathepsin L cleavage sites were identified in T1L 3, the deduced amino acid sequences of T1L and T3D differ at only 12 positions (58, 59) , and thus, conclusions based on the structure of T3D 3 are likely to be applicable to T1L 3.
We hypothesize that the C-terminal region of 3 acts as a safety latch, controlling access to the more internal cleavage sites in 3 and subsequent conversion of virions to ISVPs. Because reovirus disassembly is an acid-dependent process, this latch might be primed for movement at acidic pH. The first 3 cleavage event may remove this safety latch and allow access to the cleavage sites identified in this study at residues 243-244 and 250 -251. In viruses with mutations in the Cterminal region of 3, such as PI and D-EA viruses, the safety latch may be altered by structural rearrangements. Alterations in structure have been observed by cryoelectron microscopy and three-dimensional image analysis of viruses with the tyrosine-to-histidine mutation at residue 354 in 3. Results presented in this report provide evidence that specific endocytic proteases play distinct roles in reovirus disassembly. To mediate virion-to-ISVP conversion, murine fibroblasts have a requirement for either cathepsin B or cathepsin L, with cathepsin L being the dominant enzyme in this reaction. These findings also indicate that cathepsin B and cathepsin L have specific functions in modulating susceptibility of cells to productive infection by intracellular pathogens. Moreover, these results raise the possibility that that cathepsin B and cathepsin L may influence tropism or virulence of reovirus after infection of host organisms.
